Project Details
Description
Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus met?? XR in Subjects with Stage I-IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Prior to Definitive Treatment (Cost Reimbursable)
| Status | Finished |
|---|---|
| Effective start/end date | 9/9/16 → 8/1/21 |
Funding
- UNIVERSITY OF WISCONSIN-MADISON
- NIH NATIONAL CANCER INSTITUTE (NCI)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.